| European Leukemia Trial Registry |
| Trial: MDS Erlotinib |
| Scientific Title | Phase I/II trial of Erlotonib in high risk myelodysplastic syndrome |
| Short Title | MDS Erlotinib |
| Trialgroup | Groupe Francophone des Myélodysplasies |
| Disease | Myelodysplastic Syndrome(MDS) All subtypes |
| Age | - |
| Status | Active |
| Start of Recruitment | 01.09.2009 |
| Shortprotocol | Shortprotocol |
